Cite Filings / ORKA / 0001415889-25-005913

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Oruka Therapeutics, Inc. Filed 2025-02-27 Acc 0001415889-25-005913

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-10-17 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-03-06 POS AM Post-effective Amendment for Registration Statement
2025-03-06 S-8 Securities Offered to Employees in Benefit Plans
2025-03-06 10-K Annual Report
2025-02-27 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-27 4 10% owner bought 122,882 shares at an average $11.45 ($1,407,368)
2025-02-27 3 Initial Statement of Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…